Register
|
Login
Published News
Upcoming News
Submit a New Story
Blogs
Clinical Trials
Conferences & Events
Corporate
Financial
Product
Publications
Research & Development
RSS
3
Vote
Drug Injury Watch: Ortho Evra, Preemption, And The New York Times: Another Drug Company Response Letter
Posted by
tjlpa
870 days ago (
http://www.drug-injury.com
)
And, We Learn About More Of Merck's Vioxx Shenanigans -- Another Benefit Of Pharmaceutical Product Liability Litigation
Who Voted for this Story
worldpharmanews
G00gle
tjlpa
Related Links
Drug Injury Watch: Zyprexa And Diabetes: Is This A Tale Of Company Greed Coupled With FDA Failure?
Drug Injury Watch: FDA's Proposed Rule About Drug Label Warning Changes Will Lessen Its Power To Protect Us
Patient Lawsuits Against Pharmacuetical Companies For Drug Injuries Might Be Prohibited In U.S.
Drug Injury Watch: Sprint Fidelis Recall Showed That FDA's Medical Device Safety System Is Flawed
Drug Injury Watch: Issue: Should We Be Prohibited From Filing Product Liability Lawsuits Against Medical Device Manufacturers And Pharmaceutical Companies?
Drug Injury Watch: New Article With 25 Big Pharma Facts, And Free Online Tool To Search MedWatch Report Data
Drug Injury Watch: Did You See Ortho-McNeil's Response To April 6 NYT Article About Ortho Evra And Federal Preemption?
Drug Injury Watch: FDA's 2007 Report On Outstanding Post-approval Studies: No Progress Made By Big Pharma
Drug Injury Watch: May 2008 Congressional Hearing On Federal Preemption Of Drug And Medical Device Lawsuits
Drug Injury Watch: Court's Riegel Preemption Ruling Would Be Negated With Bill Sponsored By Democrats In Congress
Comments
Log in to comment
or register
here
.
Subscribe
Enter your email address:
Delivered by
FeedBurner
Top Users
Tag cloud
Live
Comments